DK175475B1 - Use of pSG5 as a temperature sensitive plasmid - Google Patents

Use of pSG5 as a temperature sensitive plasmid Download PDF

Info

Publication number
DK175475B1
DK175475B1 DK198901460A DK146089A DK175475B1 DK 175475 B1 DK175475 B1 DK 175475B1 DK 198901460 A DK198901460 A DK 198901460A DK 146089 A DK146089 A DK 146089A DK 175475 B1 DK175475 B1 DK 175475B1
Authority
DK
Denmark
Prior art keywords
plasmid
psg5
marker
dna
mutants
Prior art date
Application number
DK198901460A
Other languages
Danish (da)
Other versions
DK146089A (en
DK146089D0 (en
Inventor
Wolfgang Wohlleben
Guenter Muth
Alfred Puehler
Bernhard Nussbaumer
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of DK146089D0 publication Critical patent/DK146089D0/en
Publication of DK146089A publication Critical patent/DK146089A/en
Application granted granted Critical
Publication of DK175475B1 publication Critical patent/DK175475B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces

Abstract

The streptomycetes plasmid pSG5 is temperature-sensitive. It is thus possible with the aid of the pSG5 replicon to prepare temperature-sensitive hybrid plasmids. The latter are suitable for screening for DNA segments which are homologous with DNA segments of the hybrid plasmid.

Description

DK 175475 B1 IDK 175475 B1 I

i Ii

Fra europæisk patentskrift nr. 158.872 kendes Strep- IStrep-I is known from European Patent No. 158,872

tomycet-plasmidet pSG5, der kan isoleres fra en kultur af Ithe tomycet plasmid pSG5, which can be isolated from a culture of I

Streptomyces ghanaensis DSM 2932. Dette plasmid er egnet til IStreptomyces ghanaensis DSM 2932. This plasmid is suitable for I

fremstilling af hybridvektorer, især til såkaldte pendul- Iproducing hybrid vectors, especially for so-called pendulums

5 vektorer, der på grund af et indbygget E. coli-replikon I5 vectors that due to a built-in E. coli replicon I

kan formeres i E. coli-stammer. Sådanne vektorer er f.eks. Ican be propagated in E. coli strains. Such vectors are e.g. IN

I kendt fra den europæiske patentansøgning med offentiiggørel- IYou know from the European patent application with publication I

I sesnummer 158.201. IIn SE number 158.201. IN

I Det har nu ifølge opfindelsen vist sig, at pSG5 er IIt has now been found according to the invention that pSG5 is I

I 10 temperaturfølsomt. IIn 10 temperature sensitive. IN

I pSG5’s temperaturfølsomhedsegenskab er overraskende, IIn pSG5's temperature sensitivity property is surprising, I

I da der hidtil ikke har været kendt nogen naturlige Strep- IIn that so far no natural Strep-I has been known

tomycet-plasmider, der har denne egenskab. Da pSG5 og de Itomycet plasmids that have this property. Since pSG5 and the I

I med dets replikon fremstillede hybridplasmider frembyder et IHybrid plasmids prepared with its replicon present an I

15 bredt værtsområde, åbner anvendelsen ifølge opfindelsen af I15 wide host range, opens the application of the invention of I

I dette plasmid en mængde muligheder for fagmanden: IIn this plasmid, there are a number of possibilities for the skilled person:

Når man konstruerer et plasmid med replikonet fra IWhen constructing a plasmid with the replicon from I

I pSG5, der indeholder en markør, transformerer en kompatibel IIn pSG5 containing a marker transforms a compatible I

værtsstamme dermed, og derpå forhøjer temperaturen over Ihost strain thereby, and then the temperature rises above 1

I 20 tærskelværdien, fås efter selektering efter markøren kun IAt the 20 threshold, only after selection after the cursor is I obtained

I sådanne transformanter, der har plasmidet integreret helt IIn such transformants that have integrated the plasmid completely I

eller delvis i genomet. Da sådanne integreringer idet væsent- I lige kun sker i homologe områder af genomet, er denne frem- H gangsmåde egnet til at finde sådanne homologe områder i I 25 værtsstammens genom.or partially in the genome. Since such integrations essentially only occur in homologous regions of the genome, this method is suitable for finding such homologous regions in the host strain genome.

I Fra europæisk offentliggørelsesskrift nr. 243.856 I kendes en fremgangsmåde til fremstilling af mutanter, ved I hvilken man ud fra udgangsstammen isolerer den totale DNA, omdanner den til små fragmenter, integrerer disse i et plas- I 30 mid, der indeholder en markør, er temperaturf ølsom og re- I plicerer i udgangsstammen, transformerer den fremkomne hy- H bridplasmidpopulation i udgangsstammen, selekterer transfor- manterne ved selektering efter markøren, eliminerer hybrid- I plasmiderne ved forhøjelse af temperaturen over det tempe- I 35 raturfølsomme plasmids tærskelværdi og selekterer mutanterne I ved fornyet selektering efter markøren.From European Publication No. 243,856, a method for producing mutants is known, in which, from the starting strain, isolating the total DNA, converting it into small fragments, integrating them into a plasmid containing a marker is temperature sensitive and replicates in the starting strain, transforms the resulting hybrid H plasmid population into the starting strain, selects the transformants by selection after the marker, eliminates the hybrid I plasmids by raising the temperature above the temperature sensitive plasmid thresholds, and selects You re-select after the cursor.

DK 175475 B1DK 175475 B1

SS

Udtrykket "korte" fragmenter betyder DNA-afsnit, derThe term "short" fragments means DNA sections that

H fås med hyppigt skærende restriktionsenzymer såsom Sau3AH is available with frequent cutting restriction enzymes such as Sau3A

H eller Taql, men også med mekaniske metoder {ultralyd, klip- H ning), og som hverken indeholder promotorområdet eller sig- H 5 nalerne for translationsstop.H or Taql, but also by mechanical methods (ultrasound, clipping H), and containing neither the promoter region nor the translation stop signals.

H Da der efter eliminering af plasmiderne ved selek- H tering efter markøren kun overlever celler, der har optaget H plasmid-DNA i deres chromosom (hvilket fortrinsvis sker H over den i plasmidet integrerede homologe DNA), fås mutan- 10 terne umiddelbart.H Since, after elimination of the plasmids by selection after the marker, only cells that have incorporated H plasmid DNA into their chromosome (which preferably H occurs over the homologous DNA integrated into the plasmid) survive, the mutants are obtained immediately.

Plasmidet pSG5 er anført som egnet udgangsplasmid i det europæiske offentliggørelsesskrift nr. 243.856. Ifølge opfindelsen kan dog mutationen til temperaturfølsomme re- plikationsmutanter nu bortfalde ved anvendelse af dette 15 plasmid. Dermed sparer man ikke blot mutationen og den særlig I krævende selektering, men man undgår også risikoen for at danne uønskede flerdobbelte mutationer. Plasmid pSG5 er altså særlig godt egnet til denne fremgangsmåde.Plasmid pSG5 is listed as a suitable starting plasmid in European Publication No. 243,856. However, according to the invention, the mutation to temperature-sensitive replication mutants can now be eliminated using this plasmid. This not only saves the mutation and the particularly demanding selection, but also avoids the risk of creating unwanted multiple duplications. Thus, plasmid pSG5 is particularly well suited for this method.

pSG5's temperaturfølsomhed giver udtryk ved, at dette 20 plasmid bliver ustabilt ved temperaturer fra 36°C og ikke I mere replicerer. Det anvendelige temperaturområdes øvre I grænse afhænger af værtscellen. I S. venezuelae ligger den f.eks. ved 38°C, i S. lividans ved 39°C og ved S. ghanaensis I ved 45°C. Inkuberes kulturer, der indeholder pSG5 eller et I 25 derivat af dette plasmid, ved en temperatur på 36°C eller derover, "fortyndes plasmidet bort" og kan efter få genera- I tioner ikke mere påvises.The pSG5's temperature sensitivity indicates that this plasmid becomes unstable at temperatures of 36 ° C and no longer replicates. The upper limit of the applicable temperature range depends on the host cell. In S. venezuelae it lies, for example. at 38 ° C, in S. lividans at 39 ° C and at S. ghanaensis I at 45 ° C. Cultures containing pSG5 or a derivative of this plasmid are incubated at a temperature of 36 ° C or higher, the plasmid "diluted" and can no longer be detected after a few generations.

Anvendelsen ifølge opfindelsen af pSG5-replikonet I kan altså udnyttes til at finde homologe gener til et til- I 30 stedeværende gen. Man har således et brugbart alternativ I til anlæggelse af en genbank og "screening" med markerede I DNA-sonder. Dette alternativ er særlig værdifuldt, når der I ikke ved hybridiseringen fås noget oplysende resultat. En I yderligere fordel ved denne metode, at arbejde med radio- 35 aktive stoffer kan undgås.Thus, the use of the invention of the pSG5 replicon I can be utilized to find homologous genes for a present gene. Thus, there is a viable alternative I for constructing a gene bank and "screening" with labeled I DNA probes. This alternative is particularly valuable when you do not get an enlightening result in the hybridization. A further advantage of this method is that work with radioactive substances can be avoided.

Tilsvarende kan der også findes indsætningselementerSimilarly, insert elements can also be found

3 I3 I

DK 175475 B1 IDK 175475 B1 I

(IS-elementer) og transposoner, der er optaget i den under- I(IS elements) and transposons recorded in the sub-I

søgte værtsstammes genom. Anvendes nemlig det kun med mar- Isearched the host strain genome. For it is only used with mar- I

køren forsynede plasmid uden yderligere indsat DNA, står de Ithe plasmid bearing no further inserted DNA, they stand

homologe områder kun til rådighed, når der før temperatur- Ihomologous areas only available when before temperature I

5 forhøjelsen overføres et IS-element eller transposon fra I5 the elevation transmits an IS element or transposon from I

chromosomet på plasmidet. Derved gør selekteringen efter Ithe chromosome on the plasmid. This makes the selection according to I

markøren det muligt at finde sådanne DNA-elementer. Ithe marker makes it possible to find such DNA elements. IN

De nævnte undersøgelser kan foretages svarende til IThe said investigations may be carried out in accordance with I

fremgangsmåden til isolering af mutanter ifølge europæisk Ithe method for isolating mutants according to European I

10 patentskrift nr. 243.856. I10,243,856. IN

Opfindelsen medfører således en række fordele: IThe invention thus has a number of advantages:

1. På grundlag af pSG5-plasmidet findes der allerede I1. Based on the pSG5 plasmid, I already exist

en på grund af det brede værtsområde alsidigt anvendelig Ione because of the wide host range versatile usable I

vektorfamilie med forskellige selekteringsmarkører, såsom Ivector family with various selection markers such as I

15 resistens mod neomycin, thiostrepton, kanamycin (europæisk I15 resistance to neomycin, thiostrepton, kanamycin (European I

offentliggørelsesskrift nr. 158.201) og gentamycin (europæisk IPublication No. 158,201) and gentamycin (European I

offentliggørelsesskrift nr. 248.207), samt farvemarkører, IPublication No. 248,207), as well as color markers, I

såsom melanin og andre farvestoffer eller pigmenter (euro- Isuch as melanin and other dyes or pigments (euro-I

pæisk offentliggørelsesskrift nr. 257.416 og nr. 257.417). IPeak Publication Publication No. 257,416 and No. 257,417). IN

20 2. Anvender man fra den nævnte vektorfamilie et plas- I2. From the said vector family a plasmid I is used

mid med en markør, der kan selekteres i E. coli, kan den Imid with a marker selectable in E. coli, it can I

fra europæisk offentliggørelsesskrift nr. 243.856 kendte Ifrom European Publication No. 243,856 known I

fremgangsmåde udvides til anvendelsen af cosmid-banker og Imethod is extended to the use of cosmid banks and I

dermed isoleringen af store DNA-afsnit på ca. 40 kb: Inte-25 greres den i E. coli selekterbare markør i værtsens chromo-som, kan de således opståede mutanters genom overføres i en I cosmid-genbank. Selekteringen efter markøren (hensigtsmæssigt I samtidig med cosmidets egen markør) fører derpå umiddelbart I til den cosmid-klon, der er af interesse. Således spares I 30 den hidtil nødvendige, yderst krævende "screening" ved hy- I bridisering. I modsætning til den fra europæisk offentlig- I gørelsesskrift nr. 243.856 kendte fremgangsmåde kan man I således i et trin få store genområder i naboområdet til det I muterede gen med. På denne måde kan man isolere gen-"klyn- I 35 ger", dvs. f.eks. generne til en hel biosyntesevej. Man er I heller ikke længere henvist til, at der i nærheden af det I DK 175475 B1 H muterede gen er egnede snitsteder til stede til restriktions- H enzymer.thus the isolation of large DNA sections of approx. 40 kb: If the E. coli selectable marker is integrated into the chromosome of the host, the genome of the resulting mutants can be transferred into a cosmid gene bank. Selection according to the marker (conveniently together with the cosmid's own marker) then immediately leads I to the cosmid clone of interest. Thus, you save 30 hitherto extremely necessary "screening" by hybridization. Contrary to the method known from European Publication No. 243,856, one can thus obtain large genomes in the neighboring region of the mutant gene in one step. In this way, one can isolate "clusters", i.e. eg. the genes for a whole biosynthetic pathway. Also, you are no longer referred to the fact that, in the vicinity of the gene mutated in DK 175475 B1H, suitable cut sites are present for restriction H enzymes.

Η I de følgende eksempler forklares opfindelsen nærmere.Η In the following examples, the invention is further explained.

Procentangivelser refererer herved til vægten, hvis der 5 ikke foreligger andre angivelser.Percentages hereby refer to the weight if no other information is available.

Eksempel 1 H Total DNA-isolering 10 0,1 g mycelium fra en 3 dage gammel, homogeniseret H streptomycetkultur af stammen S. ghanaensis (ATCC 14672; H USA-patentskrift nr, 3.674.866), der ikke producerer melanin (mel“), pelleteres i 1 minut i en Eppendorf-centrifuge i et 1,5 ml Eppendorf-reaktionsbeholder, pelleteres i 1 minut ogExample 1 H Total DNA Isolation 10 0.1 g of mycelium from a 3 day old homogenized H streptomycet culture of S. ghanaensis strain (ATCC 14672; H United States Patent No. 3,674,866) not producing melanin (flour ") , pellet for 1 minute in an Eppendorf centrifuge in a 1.5 ml Eppendorf reaction vessel, pellet for 1 minute and

15 vaskes derpå med 0,5 ml TE (10 ml tris-HCl, 1 mm EDTA (pH15 is then washed with 0.5 ml TE (10 ml tris-HCl, 1 mm EDTA (pH

8) med 10% saccharose). Pelleten resuspenderes derpå i 0,58) with 10% sucrose). The pellet is then resuspended in 0.5

ml lysozymopløsning (0,3 M saccharose, 25 mM tris-HCl (pHml of lysozyme solution (0.3 M sucrose, 25 mM tris-HCl (pH

8), 25 mmol EDTA, 10 mg/ml lysozym) og inkuberes i 60 minut- ter ved 37°C. Efter tilsætning af 0,2 ml 5%'s SDS-opløsning H 20 og grundig blanding af opløsningen inkuberes denne i 10 I minutter ved 65°C og afkøles derpå igen til stuetemperatur.8), 25 mmol EDTA, 10 mg / ml lysozyme) and incubated for 60 minutes at 37 ° C. After adding 0.2 ml of 5% SDS solution H 2 O and thoroughly mixing the solution, it is incubated for 10 l minutes at 65 ° C and then cooled again to room temperature.

I Derefter tilsættes 10 μΐ phenol/chloroform (5 g phenol, 5Then add 10 μΐ phenol / chloroform (5 g phenol, 5

ml chloroform, 5 mg 8-hydroxyquinolin, 1 ml 0,1 M tris (pHml of chloroform, 5 mg of 8-hydroxyquinoline, 1 ml of 0.1 M tris (pH

H 8)), og blander forsigtigt på et rysteapparat (Vortex^), I 25 indtil suspensionen er homogen. Derefter centrifugeres blan- I dingen i 5 minutter i en Eppendorf-centrifuge, og den øvre, I vandige fase overføres til en ny reaktionsbeholder. Til DNA-holdige opløsning sættes 70 μΐ 3 M ikke-pufret natrium- I acetat og 700 μΐ isopropanol. Efter blanding og 15 minut- 30 ters inkubering ved stuetemperatur pelletteres DNA'en ved I centrifugering (5 minutter i Eppendorf-centrifuge), og den I ovenstående fase fjernes kvantitativt. DNA'en resuspenderes I i 300 μΐ TE og inkuberes derpå i 45 minutter ved 37°C med I 10 μΐ RNase-opløsning (50 μg RNase/ml H2O) . RNase'n inak- I 35 tiveres ved hjælp af 100 μΐ phenol/chloroform, og de dena- I turerede proteiner pelleteres (5 minutter i Eppendorfeen-H 8)), and gently mix on a shaker (Vortex ^), I 25 until the suspension is homogeneous. The mixture is then centrifuged for 5 minutes in an Eppendorf centrifuge and the upper aqueous phase transferred to a new reaction vessel. To DNA-containing solution is added 70 μΐ 3 M non-buffered sodium I acetate and 700 μΐ isopropanol. After mixing and 15 minutes of incubation at room temperature, the DNA is pelleted by centrifugation (5 minutes in Eppendorf centrifuge) and the phase I removed quantitatively. The DNA is resuspended in 300 μΐ TE and then incubated for 45 minutes at 37 ° C with I 10 μΐ RNase solution (50 μg RNase / ml H2O). The RNase is inactivated by 100 μΐ phenol / chloroform and the denatured proteins are pelleted (5 minutes in Eppendorfen

DK 175475 B1 IDK 175475 B1 I

5 I5 I

trifuge). Den DNA-holdige opløsning behandles igen med iso- Icentrifuge). The DNA-containing solution is again treated with iso-I

propanol (tilsætning af 30 μΐ 3 M natriumacetat og 400 μΐ Ipropanol (addition of 30 μΐ 3 M sodium acetate and 400 μΐ I

isopropanol, 15 minutters inkubering ved stuetemperatur). Iisopropanol, 15 minutes incubation at room temperature). IN

Den DNA-pellet, som man får efter centrifugeringen, vaskes IThe DNA pellet obtained after centrifugation is washed

5 to gange med 70%'s ethanol og pelleteres på ny. Efter tør- I5 twice with 70% ethanol and pelleted again. After dry I

ring optages DNA'en i 300 μΐ TE, og den anvendes til de Iring, the DNA is taken up into 300 μΐ TE and used for the I

følgende trin. Ithe following steps. IN

Eksempel 2 IExample 2 I

10 I10 I

Spaltning af den totale DNA med Sau3A. ICleavage of total DNA with Sau3A. IN

I 1 /ig DNA inkuberes i spaltningspuffer (50 mM tris-HCl IIn 1 µg DNA is incubated in cleavage buffer (50 mM Tris-HCl I)

I (pH 8) , 10 mM MgCl2f 50 mM NaCl) i nærværelse af en enhed II (pH 8), 10 mM MgCl 2 (50 mM NaCl) in the presence of a unit I

I Sau3A (fremstiller BRL-Gibco, Karlsruhe) i 1 time ved 37°C. IIn Sau3A (produces BRL-Gibco, Karlsruhe) for 1 hour at 37 ° C. IN

I 15 Reaktionen standses ved phenolisering, og DNA'en renses ved IThe reaction is stopped by phenolization and the DNA is purified by I

I ethanolfældning. IIn ethanol precipitation. IN

I Eksempel 3 I 20 Kloning af total-DNA-fragmenterne i plasmid pGM4 I pGM4 (europæiske offentliggørelsesskrifter nr. 257.416 og 257.417) lineariseres fuldstændigt analogt med eksempel I 2 med BamHI. Begge DNA-prøverne blandes i spaltningspufferen, opvarmes til 70°C og indstilles på ligase-reaktionsbetingel- I 25 serne ved tilsætning af mercaptoethanol (slutkoncentration I 10 mM) og ATP (0,1 mM) . I nærværelse af en enhed T4-DNA- I ( ligase (Bohringer Mannheim) inkuberes blandingen i 12 timer I ved 14°C. Herefter transformeres blandingen af protoblaster I af udgangsstammen og udstryges på regenerationsplader. Disse I .30 overlejres efter ca. 20 timer med blød agar, der indeholder I så meget thiostrepton, at slutkoncentrationen i pladen udgør I 50 ^g/ml.In Example 3 I 20 Cloning of the total DNA fragments of plasmid pGM4 I pGM4 (European Publication Nos. 257,416 and 257,417) is completely linearized analogously to Example I 2 with BamHI. Both DNA samples are mixed in the cleavage buffer, heated to 70 ° C and adjusted to the ligase reaction conditions by the addition of mercaptoethanol (final concentration I 10 mM) and ATP (0.1 mM). In the presence of a unit of T4 DNA-I (ligase (Bohringer Mannheim), the mixture is incubated for 12 hours at 14 ° C. The protoblast I mixture is then transformed from the starting strain and plated onto regeneration plates. These I.30 are superimposed after about 20 hours). with soft agar containing so much thiostrepton that the final concentration in the plate amounts to 50 µg / ml.

I 35 I DK 175475 B1I 35 I DK 175475 B1

BB

Eksempel 4Example 4

Fremstilling og selektering af mutanter H Trans formanterne inkuberes i en rystekultur i S-medium H 5 (Hopwood m.fl., "Genetic Manipulation of Streptomyces, aPreparation and Selection of Mutants H The trans formants are incubated in a shaking culture in S medium H 5 (Hopwood et al., "Genetic Manipulation of Streptomyces, a

Laboratory Manual", The John Innes Foundation, Norwich 1985) i ca. 36 timer ved 28°C. Derefter forhøjes denne temperatur til 39°C, og der inkuberes ca. 36 timer ved denne temperatur.Laboratory Manual ", The John Innes Foundation, Norwich 1985) for about 36 hours at 28 ° C. This temperature is then raised to 39 ° C and incubated for approximately 36 hours at this temperature.

H Kulturen høstes sterilt, vaskes i TE + 10% saccharose og H 10 inkuberes yderligere 48 timer ved 39°C i fuldstændigt medium med thiostrepton (20 mg/1). Derefter udstryges de således fremstillede mutanter og karakteriseres (inkubering altid ved 39°C).H The culture is harvested sterile, washed in TE + 10% sucrose and H10 incubated an additional 48 hours at 39 ° C in complete medium with thiostrepton (20 mg / l). Then the mutants thus produced are ironed out and characterized (always incubating at 39 ° C).

15 Eksempel 5Example 5

Isolering af den muterede DNAIsolation of the mutated DNA

Ud fra mutanterne isoleres DNA i overensstemmelse I med eksempel 1, skæres med et restriktionsenzym, der ikke 20 har nogen snitsteder i det integrerede plasmid, og religeres I med T4-DNA-ligase. Herved dannes det integrerede plasmid, I der nu indeholder det muterede gen, som eneste replikations- dygtige cycliske DNA. Efter retransformering i en egnet I stamme såsom S. lividans selekteres efter thiostrepton-resi- I 25 stens, og ud fra mutanterne isoleres det plasmid, der bærer det muterede gen.From the mutants, DNA according to Example 1 is isolated, cut with a restriction enzyme having no cut sites in the integrated plasmid, and relegated I with T4 DNA ligase. Hereby the integrated plasmid, which now contains the mutated gene, is formed as the only replication-capable cyclic DNA. After retransformation in a suitable I strain such as S. lividans, select for thiostrepton resistance and from the mutants, the plasmid carrying the mutated gene is isolated.

HH

Claims (6)

1. Anvendelse af pSG5-replikonet til fremstilling af temperaturfølsomme hybridplasmider.Use of the pSG5 replicon for the production of temperature-sensitive hybrid plasmids. 2. Fremgangsmåde til opdagelse af IS-elementer og 5 transposoner, kendetegnet ved, at man udstyrer , et plasmid, der indeholder pSG5-replikonet, med en markør, transformerer streptomyceter med det således dannede hybrid-plasmid, indkuberer transformanterne ved en temperatur over 36°C, selekterer efter markøren og analyserer det DNA-område, 10 over hvilket rekombinationen har fundet sted.A method for detecting IS elements and 5 transposons, characterized by equipping a plasmid containing the pSG5 replicon with a marker, transforming streptomycetes with the hybrid plasmid thus formed, incubating the transformants at a temperature above 36 ° C, selects after the marker and analyzes the DNA region over which the recombination has occurred. 3. Fremgangsmåde til fremstilling af streptomycet-mutanter, til isolering af de muterede gener og til isolering af det tilsvarende vildtype-gen, kendetegnet ved, at man ud fra streptomycet-udgangsstammen isolerer den I 15 totale DNA, omdanner den til korte fragmenter, integrerer I disse i et hybridplasmid med pSG5-replikonet, der indeholder I en markør, transformerer den opnåede hybridplasmid-population I i udgangs s tammen, selekterer transformanterne ved selektering I efter markøren, eliminerer hybridplasmiderne ved forhøjelse I 20 af temperaturen over tærskelværdien og selekterer mutanterne I ved fornyet selektering efter markøren.A method for producing streptomycet mutants, for isolating the mutated genes and for isolating the corresponding wild-type gene, characterized by isolating from the streptomycet starting strain, integrating it into 15 total DNA, integrating it into short fragments, In these, in a hybrid plasmid with the pSG5 replicon containing I a marker, the resulting hybrid plasmid population I transforms into the parent strain, selects the transformants at selection I after the marker, eliminates the hybrid plasmids at elevation I 20 by the temperature above the threshold, and selects the mutants I by re-selecting the cursor. 4. Fremgangsmåde ifølge krav 3, kendete g- I net ved, at de muterede gener isoleres fra de selekterede I mutanter. I 254. A method according to claim 3, characterized in that the mutated genes are isolated from the selected I mutants. I 25 5. Fremgangsmåde ifølge krav 4, kendeteg- I net ved, at de tilsvarende vildtype-gener isoleres ved I < hjælp af de muterede gener.5. A method according to claim 4, characterized in that the corresponding wild-type genes are isolated by the mutated genes. 6. Fremgangsmåde ifølge krav 4, kendete g- I net ved, at hybridpi asmi det med pSG5-repl ikonet indeholder I 30 en i E. coli selekterbar markør, og at der ved isoleringen I af de muterede gener anvendes en cosmid-bank. I 356. A method according to claim 4, characterized in that the hybrid plasmid containing the pSG5 replication icon contains a marker selectable in E. coli and that in isolation I of the mutated genes a cosmid bank is used. I 35
DK198901460A 1988-03-23 1989-03-22 Use of pSG5 as a temperature sensitive plasmid DK175475B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3809692A DE3809692A1 (en) 1988-03-23 1988-03-23 USE OF PSG5 AS A TEMPERATURE-SENSITIVE PLASMIDE
DE3809692 1988-03-23

Publications (3)

Publication Number Publication Date
DK146089D0 DK146089D0 (en) 1989-03-22
DK146089A DK146089A (en) 1989-09-24
DK175475B1 true DK175475B1 (en) 2004-11-08

Family

ID=6350421

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198901460A DK175475B1 (en) 1988-03-23 1989-03-22 Use of pSG5 as a temperature sensitive plasmid

Country Status (16)

Country Link
EP (1) EP0334282B1 (en)
JP (1) JP2770975B2 (en)
KR (1) KR970003961B1 (en)
AT (1) ATE108485T1 (en)
AU (1) AU615524B2 (en)
CA (1) CA1335964C (en)
DE (2) DE3809692A1 (en)
DK (1) DK175475B1 (en)
ES (1) ES2056987T3 (en)
FI (1) FI95394C (en)
HU (1) HU213350B (en)
IE (1) IE63496B1 (en)
IL (1) IL89686A (en)
NO (1) NO178157C (en)
PT (1) PT90090B (en)
ZA (1) ZA892123B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3809691A1 (en) * 1988-03-23 1989-10-12 Hoechst Ag METHOD FOR SELECTION OF LARGE DNA SECTIONS
DE4011863A1 (en) * 1990-04-12 1991-10-17 Hoechst Ag REGULATED GENE EXPRESSION IN STREPTOMYCETES
FR2688515B1 (en) * 1992-03-13 1995-03-31 Institut Rech Agronomique THERMOSENSITIVE PLASMID.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0158872B1 (en) * 1984-03-31 1989-01-18 Hoechst Aktiengesellschaft Streptomycetes plasmid psg5, process for its preparation and its use
DE3412093A1 (en) * 1984-03-31 1985-10-10 Hoechst Ag, 6230 Frankfurt HYBRID PLASMIDE WITH A STREPTOMYCETE AND ESCHERICHIA COLI REPLICON
DE3614310A1 (en) * 1986-04-28 1987-10-29 Hoechst Ag METHOD FOR ISOLATING MUTED GENES AND THE CORRESPONDING WILD-TYPE GENES
DE3627392A1 (en) * 1986-08-13 1988-04-28 Hoechst Ag COLOR MARKER FOR CLONING IN STREPTOMYCES LIVIDANS

Also Published As

Publication number Publication date
FI891335A (en) 1989-09-24
DE58908022D1 (en) 1994-08-18
KR970003961B1 (en) 1997-03-24
EP0334282A2 (en) 1989-09-27
CA1335964C (en) 1995-06-20
EP0334282A3 (en) 1989-11-29
DK146089A (en) 1989-09-24
JPH029376A (en) 1990-01-12
IL89686A0 (en) 1989-09-28
EP0334282B1 (en) 1994-07-13
HU213350B (en) 1997-05-28
DK146089D0 (en) 1989-03-22
PT90090A (en) 1989-11-10
ATE108485T1 (en) 1994-07-15
AU3158289A (en) 1989-09-28
IL89686A (en) 1994-12-29
HUT50511A (en) 1990-02-28
NO891267L (en) 1989-09-25
IE890898L (en) 1989-09-23
NO178157C (en) 1996-01-31
KR890014741A (en) 1989-10-25
PT90090B (en) 1994-06-30
FI95394B (en) 1995-10-13
JP2770975B2 (en) 1998-07-02
NO891267D0 (en) 1989-03-22
FI95394C (en) 1996-01-25
FI891335A0 (en) 1989-03-21
DE3809692A1 (en) 1989-10-12
ES2056987T3 (en) 1994-10-16
IE63496B1 (en) 1995-05-03
NO178157B (en) 1995-10-23
AU615524B2 (en) 1991-10-03
ZA892123B (en) 1989-11-29

Similar Documents

Publication Publication Date Title
CN108504657B (en) The method for knocking out HEK293T cell KDM2A gene using CRISPR-CAS9 technology
EP0233715B1 (en) Isolation and expression of genes involved in the biosynthesis of beta-lactams
WO1989007151A1 (en) Cloning systems for rhodococcus and related bacteria
AU2009256566B2 (en) Improved protein expression system
Hill et al. Properties of a mutant blocked in inducibility of messenger RNA for the galactose operon of Escherichia coli
CN113106114B (en) Factor for regulating expression efficiency of trichoderma reesei protein, regulating method and application
JP3289726B2 (en) Clavalanic acid biosynthesis gene
DK175475B1 (en) Use of pSG5 as a temperature sensitive plasmid
CN113302303A (en) Modified filamentous fungal host cells
CN114181948B (en) Method for regulating multi-cell epidermal hair differentiation of plants
JPS62259592A (en) Isolation of mutation gene and corresponding wile type gene of mutant
EP0438232A2 (en) Dna sequence conferring a plaque inhibition phenotype
US4992371A (en) Hybrid plasmids having a streptomycetes replicon and an escherichia coli replicon
DK167775B1 (en) PLASMID PSG5, METHOD OF INSULATION THEREOF, ITS APPLICATION FOR THE CONSTRUCTION OF PLASMID VECTORS, HYBRID PLASMIDES CONTAINING PSG5 OR ITS INTACT REPLICATION REGION, AND THE STREPTOMYCS GHANA 32
NZ228441A (en) Psg5 plasmid used in isolating is elements, transposons and mutated genes
EP0067564A2 (en) Composite plasmids
Dogra et al. Biotransformation of cholesterol by Micrococcus species mediated by plasmid DNA
JPH09163982A (en) Preparation of dienone macrolide
US6709859B1 (en) Chromosomal DNA Fragments Encoding Enzymes for Encoding B-Lactam Biosynthesis Enzymes, and Vector and Transformants for Their Expression
CN113265400A (en) Method for synthesizing Headful packaging type phage
US4983525A (en) Plasmids derived from actinomadura species
JPH0691825B2 (en) Streptomyces cosmid vector
Berry Molecular and bioinformatic analysis of the perA locus in Epichloë: this thesis is presented as a partial fulfilment of the requirements for the degree of Master of Science (M. Sc.) in Genetics at Massey University, Palmerston North, New Zealand
JPH0667B2 (en) Aqueous composition for nucleic acid isolation
Washkowitz et al. Part C: Generation of Human Gene Reporters Using Bacterial Artificial Chromosome Recombineering

Legal Events

Date Code Title Description
PUP Patent expired